2B3-201

2B3-201 · BBB-Therapeutics B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2B3-201, covering 2015-02-06 to 2015-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients [Phase 1]

See pricing